Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Indirect comparison of three PARP inhibitors (olaparib, niraparib, and rucaparib) as maintenance treatment in ovarian carcinoma patients responding to platinum therapy.

Literature DB >> 35652551

Indirect comparison of three PARP inhibitors (olaparib, niraparib, and rucaparib) as maintenance treatment in ovarian carcinoma patients responding to platinum therapy.

Daniele Mengato, Luca Cancanelli, Lorenzo Di Spazio, Melania Rivano, Marco Chiumente, Andrea Messori.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2022 PMID： 35652551 DOI： 10.5414/CP204243

Source DB: PubMed Journal: Int J Clin Pharmacol Ther ISSN： 0946-1965 Impact factor: 0.976

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. The "One-to-Many" Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma.

Authors: Andrea Messori; Melania Rivano; Luca Cancanelli; Vera Damuzzo; Andrea Ossato; Marco Chiumente; Daniele Mengato
Journal: Cureus Date: 2022-08-25

1 in total